4//SEC Filing
Renger John 4
Accession 0000950170-24-006704
CIK 0001805387other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:50 PM ET
Size
5.8 KB
Accession
0000950170-24-006704
Insider Transaction Report
Form 4
Renger John
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2024-01-19+87,573→ 87,573 total→ Common Stock (87,573 underlying)
Footnotes (1)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each of January 19, 2025, January 19, 2026, January 19, 2027 and January 19, 2028, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001830363
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:50 PM ET
- Size
- 5.8 KB